Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122899762 | 12289976 | 2 | F | 20150420 | 20160708 | 20160421 | 20160713 | EXP | DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-020153 | BRISTOL MYERS SQUIBB | 51.94 | YR | M | Y | 90.00000 | KG | 20160713 | CN | DE | DE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122899762 | 12289976 | 1 | PS | DACLATASVIR DIHYDROCHLORIDE | DACLATASVIR DIHYDROCHLORIDE | 1 | Oral | 60 MG, QD | 10080 | MG | Y | 206843 | 60 | MG | QD | ||||
122899762 | 12289976 | 2 | SS | SOFOSBUVIR | SOFOSBUVIR | 1 | Oral | 400 MG, UNK | Y | 0 | 400 | MG | QD | ||||||
122899762 | 12289976 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | 1200 MG, UNK | Y | 0 | 1200 | MG | QD | ||||||
122899762 | 12289976 | 4 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | U | 0 | ||||||||||
122899762 | 12289976 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 1500 MG, UNK | U | 0 | 1500 | MG | |||||||
122899762 | 12289976 | 6 | C | HUMALOG | INSULIN LISPRO | 1 | Unknown | U | 0 | ||||||||||
122899762 | 12289976 | 7 | C | PROTAPHANE | INSULIN HUMAN | 1 | Unknown | U | 0 | ||||||||||
122899762 | 12289976 | 8 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | UNK | U | 0 | |||||||||
122899762 | 12289976 | 9 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Unknown | UNK, PRN | U | 0 | |||||||||
122899762 | 12289976 | 10 | C | CANDESARTAN | CANDESARTAN | 1 | Unknown | 8 MG, UNK | U | 0 | 8 | MG | |||||||
122899762 | 12289976 | 11 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | 100 MG, UNK | U | 0 | 100 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122899762 | 12289976 | 1 | Chronic hepatitis C |
122899762 | 12289976 | 2 | Chronic hepatitis C |
122899762 | 12289976 | 3 | Chronic hepatitis C |
122899762 | 12289976 | 4 | Product used for unknown indication |
122899762 | 12289976 | 5 | Product used for unknown indication |
122899762 | 12289976 | 6 | Product used for unknown indication |
122899762 | 12289976 | 7 | Product used for unknown indication |
122899762 | 12289976 | 8 | Product used for unknown indication |
122899762 | 12289976 | 9 | Product used for unknown indication |
122899762 | 12289976 | 10 | Cardiovascular disorder |
122899762 | 12289976 | 11 | Cardiovascular disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122899762 | 12289976 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122899762 | 12289976 | Arthralgia | |
122899762 | 12289976 | Blood urine present | |
122899762 | 12289976 | Chest pain | |
122899762 | 12289976 | Decreased appetite | |
122899762 | 12289976 | Depressed mood | |
122899762 | 12289976 | Dizziness | |
122899762 | 12289976 | Fatigue | |
122899762 | 12289976 | Hypertensive crisis | |
122899762 | 12289976 | Mitral valve incompetence | |
122899762 | 12289976 | Mood altered | |
122899762 | 12289976 | Tricuspid valve incompetence |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122899762 | 12289976 | 1 | 20150316 | 20150830 | 0 | |
122899762 | 12289976 | 2 | 20150316 | 20150830 | 0 | |
122899762 | 12289976 | 3 | 20150316 | 20150830 | 0 | |
122899762 | 12289976 | 11 | 20160128 | 0 |